This information was reviewed and approved by Deborah A. Fending, RN (4/1/2019).
Increased or decreased weight, stooped shoulders or bad breath from chronic infections often make you feel less attractive to your sexual partner.
It is hard to feel motivated for sexual activity when you feel tired, depressed, unattractive, tense, or fearful.
Fear is a common emotion you or your partner may have. You or your partner may worry that kissing or sexual activity will be suffocating. This may lead to avoiding sexual activity. It is also important to realize that being sexual means more than just having sexual intercourse. Holding and touching each other, as well as enjoying time together, are also important parts of loving and being loved. Intimacy is different from sexual intercourse and can be thought of as closeness.
Clinical Trials
- Idiopathic Pulmonary Fibrosis (IPF) & GERD
- ADRN-12/LEADS (Longitudinal Endotyping of Atopic Dermatitis Through Transcriptomic Skin Analysis)
- Atopic Dermatitis & Skin Infections
- BBT-877: Possible Treatment for Idiopathic Pulmonary Fibrosis
- BEACON-CF: Investigational mRNA Therapy for Cystic Fibrosis
- Biomarkers & Hypersensitivity Pneumonitis Progression
- Blood Test to Help Identify Cancer
- Can Pembrolizumab (MK3475) with SBRT Treatment Stop or Slow Non-Small Cell Lung Cancer?
- Creating Asthma Measurements through the MORRE Study
- Effects of Pregnancy for Cystic Fibrosis Patients
- Evaluating Skin Barrier Changes in Food Allergy
- Extensive Stage Small Cell Lung Cancer Combination Treatment
- Healthy Adults Needed for Beryllium Disease Study
- Healthy People Needed for Sarcoidosis Research
- Identifying Characteristics and Patterns of Asthma
- ILD & Early Rheumatoid Arthritis
- Immune Pathways & Development of Sarcoidosis
- Improving Treatment for IPF
- Investigational Gene Therapy for Adults with CF
- Link Between Rheumatoid Arthritis & Lung Disease
- Lung Cancer & COVID Infection
- Lung Injury from Military Deployment
- MyAI Registry for People with Adrenal Insufficiency
- New Trial Medication for Pulmonary Arterial Hypertension
- OCEAN Study for EGPA
- Possible New Inhaled Treatment Option for PH with ILD
- Potential New Treatment for Metastatic Lung Cancer
- PRA023 for Systemic Sclerosis with Interstitial Lung Disease
- Predict and Prevent Lung Disease
- Predicting ILD from Hypersensitivity Pneumonitis
- Pulmonary Arterial Hypertension & increased dose of Opsumit
- Pulmonary Fibrosis & Genetic Factors
- RESOLVE-Lung Study for Pulmonary Sarcoidosis
- Silicosis Registry
- Skin Reactions to Cancer Immunotherapy
- Skin, Airway & Esophageal Epithelial Barriers in Youth
- SUNBEAM: Studying Allergy Development in Babies
- SUNRISE Trial for Oral Steroid Dependent Asthma
- Testing Blood’s Response to Foreign Substances
- Treating Deployment-Related Asthma with Supplements
- Understanding Allergy Development in Infants
- Understanding Reproductive Health Concerns in Men with CF
- Understanding Skin Problems from Eczema and Food Allergies
- XTMAB-16: A New Drug to Reduce Steroid Use in Sarcoidosis